Published in Clin Immunol on September 01, 2001
Murine models of systemic lupus erythematosus. J Biomed Biotechnol (2011) 1.84
Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med (2004) 1.70
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest (2013) 1.64
Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol (2009) 1.55
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol (2006) 1.43
Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. J Immunol (2009) 1.40
P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. Arthritis Rheum (2013) 1.28
Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol (2009) 1.26
Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J Exp Med (2002) 1.18
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis. Arthritis Rheum (2012) 1.18
Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun (2011) 1.11
Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol (2012) 1.10
B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol (2011) 1.08
Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res Ther (2011) 1.05
Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus. Arthritis Rheum (2008) 0.95
Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J Exp Med (2013) 0.94
Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. Curr Opin Immunol (2014) 0.92
Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells. Genes Immun (2010) 0.92
A female preponderance for chemically induced lupus in SJL/J mice. Clin Immunol (2006) 0.90
Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus. F1000Res (2015) 0.85
Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. Discov Med (2013) 0.84
Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure. Clin Immunol (2014) 0.84
The XX sex chromosome complement in mice is associated with increased spontaneous lupus compared with XY. Ann Rheum Dis (2012) 0.84
Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease. J Virol (2011) 0.83
Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus. Clin Dev Immunol (2012) 0.83
Quantitative trait locus analysis of ovarian cysts derived from rete ovarii in MRL/MpJ mice. Mamm Genome (2010) 0.81
Multiple loci are linked with anti-red blood cell antibody production in NZB mice -- comparison with other phenotypes implies complex modes of action. Clin Exp Immunol (2004) 0.80
TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism. J Immunol (2016) 0.79
Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice. Am J Kidney Dis (2011) 0.78
Genetic complementation results in augmented autoantibody responses to lupus-associated antigens. J Immunol (2009) 0.78
Pathogenesis of proliferative lupus nephritis from a historical and personal perspective. Clin Immunol (2016) 0.76
Drugs, sun and T cells in lupus. Clin Exp Immunol (2004) 0.75
A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus. J Immunol (2015) 0.75
Modelling clinical systemic lupus erythematosus: similarities, differences and success stories. Rheumatology (Oxford) (2016) 0.75
Genetic approach to study lupus glomerulonephritis. Methods Mol Biol (2012) 0.75
Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci U S A (1973) 18.46
Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (1995) 6.84
Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules. J Mol Biol (1974) 5.00
Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med (1975) 4.96
IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol (1975) 4.92
Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med (1979) 3.76
CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med (1990) 3.67
Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med (1985) 3.48
Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med (1974) 3.38
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science (1990) 3.17
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95
Occurrence of surface IgM, IgD, and free light chains of human lymphocytes. J Exp Med (1974) 2.93
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med (1980) 2.76
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Pathologic findings in mesangiopathic glomerulonephritis in Navajo Indians. Arch Pathol Lab Med (1989) 2.48
Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages. J Cell Biol (1983) 2.45
Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate. J Exp Med (1985) 2.41
Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med (1978) 2.39
A dynein-like protein associated with neurotubules. FEBS Lett (1974) 2.38
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol (1986) 2.31
Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J Immunol (1975) 2.28
Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. J Exp Med (1982) 2.27
Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med (1986) 2.17
Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A (1993) 2.17
The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J Exp Med (1975) 2.13
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med (1988) 2.07
Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med (1988) 2.05
Immunocytochemical studies of neurofibrillary tangles. Am J Pathol (1981) 2.01
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors. J Exp Med (1979) 1.98
The nature of the stimulatory cell in human allogeneic and autologous MLC reactions; role of isolated IgM-bearing B cells. J Immunol (1979) 1.96
Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class. Am J Pathol (1983) 1.93
Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J Exp Med (1984) 1.84
Regulation of mRNA export in response to stress in Saccharomyces cerevisiae. Genes Dev (1996) 1.80
Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc Natl Acad Sci U S A (1978) 1.78
Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76
T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol (1979) 1.74
Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol (1991) 1.69
B-cell alloantigen Ag 7a in multiple sclerosis. Lancet (1975) 1.67
Human sperm antigens and antisperm antibodies I. Studies on vasectomy patients. Clin Exp Immunol (1975) 1.53
Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev (1979) 1.53
Pathogenesis of experimental allergic orchitis. II. The role of antibody. J Immunol (1971) 1.52
Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis. J Clin Invest (1978) 1.50
Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus. Science (1989) 1.49
Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens. J Exp Med (1980) 1.47
Biochemical studies on the in vitro assembly and disassembly of microtubules. Ann N Y Acad Sci (1975) 1.46
Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies. J Immunol (1989) 1.45
Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2. J Exp Med (1994) 1.45
Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages. J Biol Chem (1985) 1.43
Murine autoimmune oophoritis, epididymoorchitis, and gastritis induced by day 3 thymectomy. Immunopathology. Am J Pathol (1987) 1.42
Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med (1975) 1.40
Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci U S A (1999) 1.39
Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J Exp Med (1992) 1.38
Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature. Cancer (1967) 1.38
Why is gramicidin valence selective? A theoretical study. Biophys J (1987) 1.37
A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum (1989) 1.37
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
Immunofluorescent studies on antibodies directed to a buried membrane structure present in lymphocytes and erythrocytes. J Immunol (1975) 1.36
Isolation and immunological characterization of a major surface glycoprotein (gp54) preferentially expressed on certain human B cells. J Exp Med (1979) 1.35
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34
Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med (1986) 1.32
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia. J Exp Med (1980) 1.28
Pathogenesis of experimental allergic orchitis. III. T lymphocyte requirement in local adoptive transfer by peritoneal exudate cells. J Immunol (1977) 1.27
Tolerance mechanism in experimental ovarian and gastric autoimmune diseases. J Immunol (1992) 1.27
Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. Proc Natl Acad Sci U S A (1994) 1.26
Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. J Clin Invest (1979) 1.26
Circulating immune complexes in disseminated gonorrheal infection. Ann Intern Med (1978) 1.26
Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol (1996) 1.25
Both immature and mature T cells mobilize Ca2+ in response to antigen receptor crosslinking. Nature (1987) 1.25
Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens. J Clin Invest (1979) 1.24
Histoplasmosis. Association with circulating immune complexes, eosinophilia, and mesangiopathic glomerulonephritis. Arch Intern Med (1979) 1.24
Human cell lines containing Epstein-Barr virus but distinct from the common B cell lymphoblastoid lines. Proc Natl Acad Sci U S A (1979) 1.24
Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines. J Exp Med (1983) 1.23
Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors. J Clin Invest (1984) 1.23
Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation. Proc Natl Acad Sci U S A (2006) 1.22
Biogenesis of membrane-bound and secreted immunoglobulins. I. Two distinct translation products of human mu-chain, with identical N-termini and different C-termini. J Exp Med (1980) 1.21
Parasitism of antigen presenting cells in hyperbacillary leprosy. Clin Exp Immunol (1984) 1.21
Immunoregulatory role of CD40 in human B cell differentiation. J Immunol (1993) 1.20
Membrane immunoglobulins of B lymphocytes: inability to detect certain characteristic IgM and IgD antigens. J Exp Med (1974) 1.19
Persistence of physiological self antigen is required for the regulation of self tolerance. J Immunol (2000) 1.19
Immunological responses of healthy elderly population. Clin Exp Immunol (1982) 1.18
Productive infection of cultured human lymphoid cells by adenovirus. J Virol (1987) 1.17
Lymphocyte surface membrane immunoglobulin. Scand J Immunol (1976) 1.17
Immunopathology of murine experimental allergic orchitis. J Immunol (1983) 1.15
Characterization of renal tissue lymphocytes in patients with interstitial nephritis. Am J Med (1981) 1.15
Detection of circulating immune complexes in the sera of rabbits with experimental syphilis: possible role in immunoregulation. Infect Immun (1980) 1.14
Hairy cell leukemia: proliferation of a cell with phagocytic and B-lymphocyte properties. Scand J Immunol (1974) 1.13
Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum (1985) 1.13
Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet (1996) 1.12
Rheumatoid factors isolated from patients with autoimmune disorders are derived from germline genes distinct from those encoding the Wa, Po, and Bla cross-reactive idiotypes. J Clin Invest (1991) 1.12
P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol (1999) 1.12
Expression and role of the T cell receptor in early thymocyte differentiation in vitro. J Immunol (1987) 1.11
J chain biosynthesis in pre-B cells and other possible precursor B cells. J Exp Med (1981) 1.10
Induction of human antibody responses in vitro with emphasis on allogeneic helper factors. Immunol Rev (1979) 1.09